AMA
Vazhnichaya E, Baliuk O, Starchenko I, Kostenko V, Akimov O. Ethylmethylhydroxypyridine Succinate Effects in the Management of Acute Ultraviolet Skin Damage. Dermatology Review/Przegląd Dermatologiczny. 2025;112(1):1-9. doi:10.5114/dr.2025.152302.
APA
Vazhnichaya, E., Baliuk, O., Starchenko, I., Kostenko, V., & Akimov, O. (2025). Ethylmethylhydroxypyridine Succinate Effects in the Management of Acute Ultraviolet Skin Damage. Dermatology Review/Przegląd Dermatologiczny, 112(1), 1-9. https://doi.org/10.5114/dr.2025.152302
Chicago
Vazhnichaya, Elena, Olena Baliuk, Ivan Starchenko, Vitalii Kostenko, and Oleg Akimov. 2025. "Ethylmethylhydroxypyridine Succinate Effects in the Management of Acute Ultraviolet Skin Damage". Dermatology Review/Przegląd Dermatologiczny 112 (1): 1-9. doi:10.5114/dr.2025.152302.
Harvard
Vazhnichaya, E., Baliuk, O., Starchenko, I., Kostenko, V., and Akimov, O. (2025). Ethylmethylhydroxypyridine Succinate Effects in the Management of Acute Ultraviolet Skin Damage. Dermatology Review/Przegląd Dermatologiczny, 112(1), pp.1-9. https://doi.org/10.5114/dr.2025.152302
MLA
Vazhnichaya, Elena et al. "Ethylmethylhydroxypyridine Succinate Effects in the Management of Acute Ultraviolet Skin Damage." Dermatology Review/Przegląd Dermatologiczny, vol. 112, no. 1, 2025, pp. 1-9. doi:10.5114/dr.2025.152302.
Vancouver
Vazhnichaya E, Baliuk O, Starchenko I, Kostenko V, Akimov O. Ethylmethylhydroxypyridine Succinate Effects in the Management of Acute Ultraviolet Skin Damage. Dermatology Review/Przegląd Dermatologiczny. 2025;112(1):1-9. doi:10.5114/dr.2025.152302.